Intervention group (n = 31) | Placebo group (n = 21) | p-value* | |
---|---|---|---|
Age (mean, SD) | 55 (7) | 55 (11) | 0,97 |
%Male /%Female | 61/39 | 43/58 | 0,26 |
Mean total cholesterol in mg/dl (SD) | 244 (28) | 233 (26) | 0,16 |
Mean HDL in mg/dL (SD) | 66 (17) | 60 (16) | 0,21 |
Mean LDL in mg/dL (SD) | 154 (29) | 148 (22) | 0,42 |
Mean TG in mg/dL (SD) | 119 (53) | 120 (62) | 0,93 |
Mean systolic blood pressure (SD) | 118 (8,5) | 123 (10,8) | 0,10 |
Mean diastolic blood pressure (SD) | 74 (8,1) | 77 (6,7) | 0,14 |
Smokers | 0 | 1 | 0,40 |
Former smokers | 12 | 5 | 0,37 |
Diabetes/impaired glucose tolerance | 1 | 2 | 0,56 |
Family history of cardiovascular risk** | 2 | 2 | 1,00 |
Cardiovascular risk profile***, median risk (range) | 2 (0–5) | 2 (0–4) | 0,21 |